Sichuan supports the whole industrial chain of pharmaceutical innovation 5 years to form 50 national-level platforms

Sichuan on the medicine innovation
the industry chain support 5 years
the formation of
50 state-level platform
China Securities Network On March 17 from the central government portal network, the Sichuan Provincial Government Office issued "accelerating the of pharmaceutical
industry innovation development of the implementation of the of the
industry chain support the Sichuan provincial government said that by 2020, to form 50 national innovation platform
, 100 provincial-level innovation platforms, Sichuan Province, the cultivation area of Chinese herbal medicine up to 4 million mu, the completion of the Chinese herbal medicine production quality management norms (GAP) base 50, the pharmaceutical industry strive to achieve the high-level talent team "10 million" target If the achievement of a job invention is successfully converted from a finisher, it may enjoy a distributable net income of not less than 70% Medical research personnel in institutions of higher learning and scientific research institutions are encouraged to participate in part-time and part-time cooperation in industry, research and research, and to start their own businesses, participate in or preside over scientific research activities in enterprises by way of part-time or off-duty status the Opinions put forward seven key work plans, covering joint innovation, technological upgrading, the development of Chinese medicine, emerging industries, market circulation, personnel training, open cooperation and so on "Opinion" put forward for the first time to obtain the national new drug certificate of drugs in Sichuan industrialization, to give a maximum of 5 million yuan reward; the Opinion, the support for new drug research and development extends to pre-clinical, pre-clinical and clinical-stage creative research and development in stages to support, innovation failure, in line with the provisions of the research and development costs to compensate a certain proportion To obtain the national pharmaceutical industry innovation platform, etc , to obtain GAP certification of the Taodi Chinese herbal medicine planting base, pharmaceutical enterprises research and development investment accounted for 3% of operating income, etc , to give a certain amount of subsidies or incentives in order to guide all kinds of social funds into the pharmaceutical industry, the Opinions propose to give incentives to financial institutions and other institutions that extend loans to the corresponding key pharmaceutical enterprises and small micro-pharmaceutical enterprises Sichuan Province will also support the establishment of pharmaceutical industry innovation, venture capital fund, financial funds will be supporting the fund or equity participation "Opinion" supports the transformation of scientific research and protect the rights and interests of research and development personnel, put forward the job scientific and technological achievements from the unit conversion success, the completion of the results to give a one-time reward, at the same time in the patent period from the annual after-tax income to extract not less than 5% as the inventor (designer) compensation For inventions of pharmaceutical jobs that have not been converted within one year, the person or team who completes the results shall have the right to dispose of the results in the market circulation, the Opinions give the same price policies for the province in terms of public procurement, price and marketing, such as new drugs, health services, medical equipment, etc., and social health care and health service institutions to implement the same price policies as public medical institutions Regarding the incentive and subsidy funds, Sichuan Province will be included in the provincial government's special financial funds support, and budget co-ordination related news